Europe Acne Medication Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)

No. of Pages: 127
Report Code: BMIRE00030657
Category: Life Sciences
Europe Acne Medication Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Acne Medication Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Acne Medication Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Acne Medication Market Regional Analysis

6.2 Europe Acne Medication Market Revenue 2020-2030 (US$ Million)
6.3 Europe Acne Medication Market Forecast Analysis

7. Europe Acne Medication Market Analysis – by Therapeutic Class

7.1 Retinoids
  • 7.1.1 Overview
  • 7.1.2 Retinoids: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Benzoyl Peroxide
  • 7.2.1 Overview
  • 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Antibiotics: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Salicylic Acid
  • 7.4.1 Overview
  • 7.4.2 Salicylic Acid: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Acne Medication Market Analysis – by Formulation

8.1 Topical Medication and Oral Medication
  • 8.1.1 Overview
  • 8.1.2 Topical Medication and Oral Medication: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Acne Medication Market Analysis – by Acne Type

9.1 Non-Inflammatory Acne and Inflammatory Acne
  • 9.1.1 Overview
  • 9.1.2 Non-Inflammatory Acne and Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Acne Medication Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Acne Medication Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 Europe Acne Medication Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 UK: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.1.2 UK: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.1.3 UK: Europe Acne Medication Market Breakdown, by Acne Type
  • 10.2.1.2 Germany: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.2.2 Germany: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.2.3 Germany: Europe Acne Medication Market Breakdown, by Acne Type
  • 10.2.1.3 France: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 France: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.3.2 France: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.3.3 France: Europe Acne Medication Market Breakdown, by Acne Type
  • 10.2.1.4 Russia: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.4.2 Russia: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.4.3 Russia: Europe Acne Medication Market Breakdown, by Acne Type
  • 10.2.1.5 Italy: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.5.2 Italy: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.5.3 Italy: Europe Acne Medication Market Breakdown, by Acne Type
  • 10.2.1.6 Rest of Europe: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Acne Medication Market Breakdown, by Therapeutic Class
    • 10.2.1.6.2 Rest of Europe: Europe Acne Medication Market Breakdown, by Formulation
    • 10.2.1.6.3 Rest of Europe: Europe Acne Medication Market Breakdown, by Acne Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Teva Pharmaceutical Industries Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Almirall SA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Johnson & Johnson
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Bausch Health Companies Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Galderma SA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pfizer Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 GSK Plc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Viatris Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Pierre Fabre SA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Acne Medication Market

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Pierre Fabre SA
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)